Papers
1
Total Citations
22
H-Index
1
About
Dr. Xiuping Liu is a leading researcher in the field of inflammatory breast cancer (IBC), the most lethal and aggressive form of breast cancer. Her work focuses on developing and utilizing patient-derived models to bridge the critical gap between preclinical research and effective clinical therapies. Dr. Liu’s major contribution includes the creation of a clinically relevant patient-derived xenograft (PDX) ex vivo model, which allows for the direct evaluation of tumor-specific therapies in a setting that closely mimics human disease. This innovative approach is vital for testing new treatments and understanding the unique biology of IBC, a rare cancer with a 5-year survival rate of only 62-68%. Her most-cited paper on this model has garnered 22 citations, highlighting its importance to the field. By providing a platform for personalized medicine and drug screening, Dr. Liu’s work is paving the way for improved early detection and more effective, targeted therapies for patients facing this devastating disease.
Research Focus
Key Achievements
Top Papers
- 1